1,536 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by True Vision MN LLC

True Vision MN LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,536 shares of the company's stock, valued at approximately $531,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Farther Finance Advisors LLC grew its holdings in HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after purchasing an additional 242 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in HCA Healthcare by 2.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after purchasing an additional 105 shares during the period. GAMMA Investing LLC grew its holdings in HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after purchasing an additional 737 shares during the period. Brighton Jones LLC purchased a new stake in HCA Healthcare in the fourth quarter worth about $1,021,000. Finally, OLD National Bancorp IN lifted its stake in shares of HCA Healthcare by 5.2% in the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock worth $362,000 after buying an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several analyst reports. Guggenheim initiated coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Stock Down 0.0%

Shares of NYSE HCA traded down $0.13 during trading hours on Thursday, hitting $378.31. 1,584,425 shares of the stock were exchanged, compared to its average volume of 1,462,618. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The company has a market cap of $91.01 billion, a PE ratio of 16.82, a PEG ratio of 1.30 and a beta of 1.47. The firm has a fifty day moving average price of $373.87 and a 200-day moving average price of $340.71. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.36 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.